Kidoz director options expire; 431,250 still held

Kidoz Inc. director Claes Kalborg reported an update to his stock option holdings.

Rhea-AI Filing Summary

Kidoz Inc. director Claes Kalborg reported an update to his stock option holdings. On February 1, 2026, 50,000 employee stock options with an exercise price of approximately US$0.39 expired unexercised, recorded with transaction code "E" for an expiration event.

After this change, Kalborg beneficially owns a total of 431,250 employee stock options in Kidoz Inc., all held directly. These options come from several prior grants between 2021 and 2025, with exercise prices ranging from approximately US$0.147 to US$0.813 and expirations from 2026 through 2030. The footnotes state that the grants generally vest at a rate of 2% per month, reflecting ongoing vesting schedules tied to his role with the company.

Insider Trade Summary

Derivative Expiration: 50,000 shares

Derivative Expiration 6 txns

Insider Kalborg Claes

Role Director

Type	Security	Shares	Price	Value
Derivative Expiration	Employee Stock Option (Right to Buy)	50,000	$0.39	$20K
holding	Employee Stock Option (Right to Buy)	--	--	--
holding	Employee Stock Option (Right to Buy)	--	--	--
holding	Employee Stock Option (Right to Buy)	--	--	--
holding	Employee Stock Option (Right to Buy)	--	--	--
holding	Employee Stock Option (Right to Buy)	--	--	--

Holdings After Transaction: Employee Stock Option (Right to Buy) — 862,500 contracts for 431,250 underlying shares (Direct)

Footnotes (6)

1. F1. Mr C. Kalborg 50,000 options in Kidoz Inc at CAD$0.50 (approximately US$0.39) expired unexercised.
2. F2. Mr. C. Kalborg was granted 50,000 stock options at CAD$1.02 (approximately US$0.813) on April 6, 2021. These options vest at 2% per month.
3. F3. Mr. C. Kalborg was granted 50,000 stock options at CAD$0.50 (approximately US$0.39) on February 1, 2022. These options vest at 2% per month.
4. F4. Mr. C. Kalborg was granted 50,000 stock options at CAD$0.30 (Approximately US$0.22) on February 21, 2023. These options vest at 2% per month.
5. F5. Mr. C. Kalborg was granted 231,250 stock options at CAD$0.20 (US$0.147) on March 26, 2024. These options vest at 2 percent per month.
6. F6. Mr. C. Kalborg was granted 50,000 options of Kidoz Inc. with an exercise price of CAD$0.25 (approximately US$0.18) on August 21, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Kidoz (KDOZF) director Claes Kalborg report in this Form 4?

He reported that 50,000 employee stock options with an exercise price of about US$0.39 expired unexercised on February 1, 2026. Following this expiration event, he continues to hold 431,250 employee stock options in Kidoz Inc., all reported as directly owned.

How many Kidoz (KDOZF) stock options does Claes Kalborg now beneficially own?

After the reported expiration, Claes Kalborg beneficially owns 431,250 employee stock options in Kidoz Inc. These options arise from multiple grants between 2021 and 2025, with different exercise prices and expiration dates, and are all listed in the filing as directly owned by him.

What happened to the 50,000 Kidoz (KDOZF) options expiring on February 1, 2026?

50,000 Kidoz Inc. stock options held by Claes Kalborg expired unexercised on February 1, 2026 at an exercise price of CAD$0.50, approximately US$0.39. The Form 4 records this event with transaction code "E," indicating an expiration rather than a sale or purchase.

What are the exercise prices of Claes Kalborg’s Kidoz (KDOZF) option grants?

His grants have exercise prices ranging from CAD$0.20 to CAD$1.02, described as approximately US$0.147, US$0.18, US$0.22, US$0.39, and US$0.813. Each grant’s Canadian-dollar exercise price and corresponding U.S. dollar equivalent are detailed in the explanatory footnotes to the Form 4.

How do Claes Kalborg’s Kidoz (KDOZF) options vest according to the filing?

The filing states that several of Claes Kalborg’s Kidoz stock option grants vest at 2% per month. This monthly vesting rate is explicitly mentioned for the grants dated April 6, 2021, February 1, 2022, February 21, 2023, and March 26, 2024 in the Form 4 footnotes.

What are the expiration dates for the Kidoz (KDOZF) options held by Claes Kalborg?

The options reported have expiration dates ranging from February 1, 2026 through August 21, 2030. Specific grants expire on February 1, 2026, April 6, 2026, February 1, 2027, February 21, 2028, March 25, 2029, and August 21, 2030, as listed in the derivative securities table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/06/2026 - 07:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kalborg Claes

(Last) (First) (Middle)

TATTBYVAGEN 11

(Street)

SALTSJOBADEN V7 133 34

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
KIDOZ INC. [ KDOZF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$0.39	02/01/2026	02/01/2026	E			50,000(1)	02/01/2021	02/01/2026	Common Stock	50,000	$0.39	431,250	D
Employee Stock Option (Right to Buy)	$0.81							04/06/2021	04/06/2026	Common Stock	50,000(2)		431,250	D
Employee Stock Option (Right to Buy)	$0.39							02/21/2022	02/01/2027	Common Stock	50,000(3)		431,250	D
Employee Stock Option (Right to Buy)	$0.22							02/21/2023	02/21/2028	Common Stock	50,000(4)		431,250	D
Employee Stock Option (Right to Buy)	$0.147							03/26/2024	03/25/2029	Common Stock	231,250(5)		431,250	D
Employee Stock Option (Right to Buy)	$0.18							08/21/2025	08/21/2030	Common Stock	50,000(6)		431,250	D

Explanation of Responses:

1. Mr C. Kalborg 50,000 options in Kidoz Inc at CAD$0.50 (approximately US$0.39) expired unexercised.

2. Mr. C. Kalborg was granted 50,000 stock options at CAD$1.02 (approximately US$0.813) on April 6, 2021. These options vest at 2% per month.

3. Mr. C. Kalborg was granted 50,000 stock options at CAD$0.50 (approximately US$0.39) on February 1, 2022. These options vest at 2% per month.

4. Mr. C. Kalborg was granted 50,000 stock options at CAD$0.30 (Approximately US$0.22) on February 21, 2023. These options vest at 2% per month.

5. Mr. C. Kalborg was granted 231,250 stock options at CAD$0.20 (US$0.147) on March 26, 2024. These options vest at 2 percent per month.

6. Mr. C. Kalborg was granted 50,000 options of Kidoz Inc. with an exercise price of CAD$0.25 (approximately US$0.18) on August 21, 2025.

	/s/ C. Kalborg	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.